Semaglutide use may be increasing worldwide rates of ischemic optic neuropathy and retinal adverse events, a study suggests.

Variants of obesity-related genes influence how much weight patients lose on specific weight loss drugs like liraglutide, two studies report.

SGLT2 inhibitors have become a major drug used to treat diabetes, heart failure, and chronic kidney disease. However, there ...

As part of its ongoing bankruptcy, Rite Aid recently added several more stores to its closure list, including two in Spokane. Rite Aid currently has seven locations in Spokane after it closed its ...

After digesting Cardinal Health's 2025 investor day, we inched up our 2026 revenue and EPS assumptions and lifted our stage II growth rates by 50 basis points to reflect a stronger distribution market ...

Semaglutide medications like Ozempic and Wegovy have shown proven results for managing conditions like type 2 diabetes and obesity. Also known as GLP-1 agonists, these drugs work by mimicking a ...

Tufts University scientists are aiming to revolutionize the future of weight loss drugs by engineering a new compound that ...

Weight loss drugs like Ozempic and Wegovy are used by over 15 million adults in the U.S., or 4.5% of the population. Despite their effectiveness, they ...

The U.S. Food and Drug Administration has approved George Medicines' Widaplik (telmisartan, amlodipine, and indapamide) for ...

Other factors that influence the impact include how much people need to eat to full feel. Researchers say they have a new ...

Novo Nordisk’s drugs are being linked to an eye condition that can cause vision loss, while health tech companies made CNBC’s ...

“Anthony’s deep expertise in financial strategy will be instrumental as Vivani advances its pipeline and scales its operations,” said Vivani Chief Executive Officer Adam Mendelsohn, PhD. “We are ...